Answers are grounded in this paper and cite their sources.
Clinical trial randomization schemes to control patient characteristics that can influence clinical response are not sufficient to control for their effects on operational efficiency and cost within the provider institution. This variation can result in biased economic findings when patients are allowed to select a provider themselves.
No takes yet. Share an insight, caveat, or question.
Ellwein et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: